The Latest Cardiac and Vascular News
Extends HeartBeam’s Reach with FDA-cleared Halo+™ Atrial Fibrillation Detection System and Physician-prescribed Integrated Patient Care Platform SANTA CLARA, Calif.–(BUSINESS WIRE)–HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (VECG) platform for heart attack detection anytime, anywhere, today announced the strategic acquisition of substantially […]
First-in-class SK channel inhibition proof of mechanism achieved First new approach to treating Atrial Fibrillation for 20 years COPENHAGEN, Denmark, March 14, 2023 /PRNewswire/ — Acesion Pharma (“Acesion”), the biotech pioneering first-in-class novel therapies for Atrial Fibrillation (“AF”), the most common cardiac arrhythmia, today announced positive data from its Phase 2 trial of […]
March 07, 2023 For the first time, patients will no longer need to travel abroad for treatment of acute cardiac diseases, as the Gibraltar Health Authority prepares to provide local coronary angiography and angioplasty services in a new interventional cardiac suite Amsterdam, the Netherlands and Gibraltar – Royal Philips (NYSE: PHG, AEX: […]
Shockwave L⁶ Provides Physicians with Larger-Diameter Catheters to Expand Potential Treatment of Peripheral Vessels SANTA CLARA, Calif., March 14, 2023 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, today announced the full U.S. commercial availability […]
BURLINGTON, Mass., March 14, 2023 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants and services, today announced that it has signed a definitive agreement to buy out its Thai distributor, Prompt Serve, for $688,000. In 2022 Prompt Serve purchased $950,000 of LeMaitre devices which […]
STOCKHOLM, SWEDEN March 14, 2023. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that the founder of its portfolio company AnaCardio, Professor Lars Lund, has published an article on a heart failure study in the scientific journal European Heart Journal. The study’s publication reinforces the company’s efforts to develop a […]
SCHAFFHAUSEN, CH / ACCESSWIRE / March 13, 2023 / Occlutech Holding AG (“Occlutech”), one of the world’s leading providers of minimally invasive structural heart disease devices, continues its progress in the US market. Today, the company has announced that the first patient has been enrolled in the FROST-HF study. The FROST-HF […]
Image Viewer is a comprehensive, intuitive solution for clinical trial imaging needs, providing real-time, on-demand viewing and manipulation at high resolution New Image Viewer Tool provides real-time on-demand images for clinical trials Viewing and manipulating images taken during clinical trials was a complex and time-consuming process that now can be […]
– Findings show intra-vascular access via the radial artery can successfully be used as the primary strategy for the modern embolization practice – SOMERSET, N.J., March 13, 2023 /PRNewswire/ — Terumo Medical Corporation (TMC) is pleased to announce the final results of its study demonstrating the safety and efficacy of Radial Access in […]
Medical imaging AI companies collaborate to offer CINA-iPE on TeraRecon’s Eureka Clinical AI platform. CAMBRIDGE, Mass., March 13, 2023 /PRNewswire/ — ConcertAI’s TeraRecon, the advanced visualization and AI Clinical SaaS category leader, today announced a partnership to offer medical imaging AI specialist Avicenna.AI‘s CINA-iPE solution detecting the presence of incidental pulmonary embolisms as part of […]
